Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 113

Sort by

Sort Order Select

Journal Articles

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study

Jeremy S. Abramson, Scott R. Solomon, Jon Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Ken Ogasawara, Manali Kamdar

Blood (2023) 141 (14): 1675–1684.

https://doi.org/10.1182/blood.2022018730

Published: 2023

Includes: Supplemental data

Journal Articles

Day 100 Peripheral Blood Natural Killer Cell/CD14+HLA-DR - Ratio Predicts Clinical Outcomes in Lymphoma Patients Treated with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Urshila Durani, Svetomir N. Markovic

Blood (2022) 140 (Supplement 1): 10577–10578.

https://doi.org/10.1182/blood-2022-163724

Published: 2022

Journal Articles

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Blood (2022) 140 (Supplement 1): 10942–10944.

https://doi.org/10.1182/blood-2022-164785

Published: 2022

Journal Articles

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Blood (2022) 140 (Supplement 1): 2399–2401.

https://doi.org/10.1182/blood-2022-167187

Published: 2022

Journal Articles

Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

Charles Gaulin, Matthew Ulrickson, Muhammad Husnain, Madiha Iqbal, Paschalis Vergidis, Allison C. Rosenthal, Hemant S. Murthy, Carolyn Mead-Harvey, Yucai Wang, Januario E. Castro, Jeanne M. Palmer, Jose F. Leis, Patrick B. Johnston, Janis E. Blair, Mohamed A. Kharfan-Dabaja, Yi Lin, Javier Munoz

Blood (2022) 140 (Supplement 1): 12111–12113.

https://doi.org/10.1182/blood-2022-159744

Published: 2022

Journal Articles

Prognosis Score for Overall Survival with CAR-T Therapy in Aggressive Lymphoma

Radhika Bansal, Arushi Khurana, Matthew Jankowski, Matthew A. Hathcock, N. Nora Bennani, Jonas Paludo, Yucai Wang, Urshila Durani, Paul J. Hampel, Stephen M. Ansell, Patrick B. Johnston, Yi Lin

Blood (2022) 140 (Supplement 1): 9504–9505.

https://doi.org/10.1182/blood-2022-167622

Published: 2022

Journal Articles

Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL): Primary Analysis of the Randomized, Phase 3 Transform Study

Jeremy S. Abramson, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Manali Kamdar

Blood (2022) 140 (Supplement 1): 1581–1583.

https://doi.org/10.1182/blood-2022-159702

Published: 2022

Journal Articles

Impact of Novel Agents on the Outcomes of Patients with Classic Hodgkin Lymphoma That Relapsed after Autologous Stem Cell Transplant

Aung M Tun, Yucai Wang, Aasiya Matin, David J. Inwards, Patrick B. Johnston, Ivana N. Micallef, Luis F. Porrata, Jose C. Villasboas, Jonas Paludo, Han W. Tun, Allison C. Rosenthal, James R. Cerhan, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell

Blood (2021) 138 (Supplement 1): 1373.

https://doi.org/10.1182/blood-2021-154038

Published: 2021

Journal Articles

Improvement in Outcomes of Autologous Stem Cell Transplant in Patients with Lymphoma Older Than 70 Years: The Significance of Age in 2020s?

Kitsada Wudhikarn, Bradley K. Johnson, Jose C. Villasboas, Jonas Paludo, David J. Inwards, Luis F. Porrata, Ivana N. Micallef, Stephen M. Ansell, Patrick B. Johnston

Blood (2021) 138 (Supplement 1): 2908.

https://doi.org/10.1182/blood-2021-144507

Published: 2021

Journal Articles

Central Nervous System Involvement By Mantle Cell Lymphoma

Nicole McLaughlin, Jonas Paludo, Yucai Wang, David J. Inwards, Nora Bennani, Gita Thanarajasingam, Jose C. Villasboas, Grzegorz S. Nowakowski, Luis F. Porrata, Carrie A. Thompson, Ivana N. Micallef, Patrick B. Johnston, Thomas E. Witzig, Thomas M. Habermann, Stephen M. Ansell

Blood (2021) 138 (Supplement 1): 2426.

https://doi.org/10.1182/blood-2021-148447

Published: 2021

Journal Articles

Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy

Blood (2021) 138 (Supplement 1): 568.

https://doi.org/10.1182/blood-2021-149103

Published: 2021

Journal Articles

Parsaclisib in Combination with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Preliminary Results of a Phase 1/1b Study

Yucai Wang, Betsy Laplant, Rebecca L. King, Ivana N. Micallef, Stephen M. Ansell, Han W. Tun, Madiha Iqbal, Gita Thanarajasingam, Allison C. Rosenthal, David J. Inwards, Patrick B. Johnston, Luis F. Porrata, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski

Blood (2021) 138 (Supplement 1): 1415.

https://doi.org/10.1182/blood-2021-147507

Published: 2021

Journal Articles

Immunologic Autograft Engineering: 13 Years Follow-up

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Svetomir N. Markovic

Blood (2021) 138 (Supplement 1): 3936.

https://doi.org/10.1182/blood-2021-148454

Published: 2021

Journal Articles

Response to Bridging Therapy As a Predictor of Outcomes for Chimeric Antigen Receptor Therapy in Large B-Cell Lymphoma

Arushi Khurana, Matthew Hathcock, Radhika Bansal, Yucai Wang, Jonas Paludo, Jose C. Villasboas, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin

Blood (2021) 138 (Supplement 1): 3841.

https://doi.org/10.1182/blood-2021-154186

Published: 2021

Journal Articles

Vaccine Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy

Radhika Bansal, Paschalis Vergidis, Pritish K Tosh, John Wilson, Matthew Hathcock, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Stephen M. Ansell, Patrick B. Johnston, Catherine Freeman, Yi Lin

Blood (2021) 138 (Supplement 1): 3857.

https://doi.org/10.1182/blood-2021-153500

Published: 2021

Journal Articles

Peak Absolute Lymphocyte Count Post CAR-T Is Associated with Clinical Response and Survival Outcome in Aggressive Lymphoma

Radhika Bansal, Anatilde Gonzalez Guerrico, Henan Zhang, Zuoyi Shao, Elham Babadi, Kodi E Marinez, Gabrielle Gonzalez McCoy, Matthew A Hathcock, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Yucai Wang, Stephen M. Ansell, Patrick B. Johnston, Jose C Villasboas, Yi Lin

Blood (2021) 138 (Supplement 1): 3856.

https://doi.org/10.1182/blood-2021-151295

Published: 2021

Journal Articles

Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience

Arushi Khurana, Radhika Bansal, Matthew Hathcock, Adrienne Nedved, Yucai Wang, Jonas Paludo, Jose C Villasboas, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin

Blood (2021) 138 (Supplement 1): 3842.

https://doi.org/10.1182/blood-2021-152313

Published: 2021

Journal Articles

Characteristics, Management and Outcomes of Patients with Intravascular Lymphoma: A Mayo Clinic Experience

Karan Seegobin, Muhamad Alhaj Moustafa, Umair Majeed, Liuyan Jiang, David Menke, Ke Li, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Madiha Iqbal, Grzegorz S. Nowakowski, Thomas M. Habermann, Thomas E. Witzig, Patrick B. Johnston, Carrie A. Thompson, Stephen M. Ansell, Han W. Tun

Blood (2021) 138 (Supplement 1): 1452.

https://doi.org/10.1182/blood-2021-146408

Published: 2021

Journal Articles

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

Blood (2021) 138 (Supplement 1): 1750.

https://doi.org/10.1182/blood-2021-151859

Published: 2021

Journal Articles

PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts

Sanjal H Desai, Levi D. Pederson, Betsy Laplant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski

Blood (2021) 138 (Supplement 1): 2508.

https://doi.org/10.1182/blood-2021-151276

Published: 2021

NARROW

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study

Day 100 Peripheral Blood Natural Killer Cell/CD14+HLA-DR - Ratio Predicts Clinical Outcomes in Lymphoma Patients Treated with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

Prognosis Score for Overall Survival with CAR-T Therapy in Aggressive Lymphoma

Impact of Novel Agents on the Outcomes of Patients with Classic Hodgkin Lymphoma That Relapsed after Autologous Stem Cell Transplant

Improvement in Outcomes of Autologous Stem Cell Transplant in Patients with Lymphoma Older Than 70 Years: The Significance of Age in 2020s?

Central Nervous System Involvement By Mantle Cell Lymphoma

Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy

Parsaclisib in Combination with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Preliminary Results of a Phase 1/1b Study

Immunologic Autograft Engineering: 13 Years Follow-up

Response to Bridging Therapy As a Predictor of Outcomes for Chimeric Antigen Receptor Therapy in Large B-Cell Lymphoma

Vaccine Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy

Peak Absolute Lymphocyte Count Post CAR-T Is Associated with Clinical Response and Survival Outcome in Aggressive Lymphoma

Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience

Characteristics, Management and Outcomes of Patients with Intravascular Lymphoma: A Mayo Clinic Experience

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only